The Pediatric Brain Tumor Foundation’s PLGA Fund and the American Association for Cancer Research (AARC) are excited to announce a request for proposals for the inaugural Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients. This grant represents a joint commitment to promote and support innovative, collaborative research focused on the most common forms of pediatric brain cancer – low-grade glioma and astrocytoma (PLGA).
While this project is specifically targeted to PLGA brain cancer, it holds great potential for all kids with brain tumors by laying the foundation for a better understanding of drug dosing across the wide spectrum of pediatric brain tumor types.
“We are at the very beginning of a field of study that hasn’t been explored before when it comes to understanding the pharmacodynamics of drug dosing in children. While we know that…
